loder

Global Allergy Immunotherapy Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis 2024 - 2031

Allergy Immunotherapy Market - By Type: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT). By Allergy Type: Seasonal Allergies, Perennial Allergies, Food Allergies, Others. By End-user: Hospitals, Clinics, Homecare. By Region: North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.

Report Code
CVMI2412247
Published
March 3, 2025
Last Updated
March 3, 2025
Coverage
Healthcare • Healthcare
Analyst-led, consultative delivery
Enterprise-ready licensing options
Fast turnarounds for custom cuts

Market Snapshot

High-signal KPIs designed for executive scanning.
Indicative snapshot. Request sample for full model outputs.
Market Size (latest)
vs. prior year
CAGR
Forecast window:
Forecast Period
2024–2031
Base years: 2019–2023
Coverage Depth
Segments • Regions • Players

Insights

Consultative narrative + actionable decision support.

The global Allergy Immunotherapy Market was valued at 2.9 billion in 2023 and is projected to reach 6.7 billion by 2031, growing at a CAGR of 10.8%. Rising environmental allergies, increasing adoption of biologics, and patient preference for long-term solutions drive growth.

2024 Market Breakthroughs

  • Biologic Therapies:
    • ALK-Abelló’s Palforzia® (peanut allergy) sales up 65% YoY.
    • Stallergenes’ Oralair® achieves 90% efficacy in pediatric trials.
  • Sublingual Tablets (SLIT):
    • FDA fast-tracks 3 new grass pollen SLIT therapies.
    • SLIT adoption grows 25% annually in Europe.
  • Personalized Vaccines:
    • DBV Technologies’ Viaskin™ Patch for milk allergy enters Phase III.

Market Drivers

1. Epidemic-Level Allergy Rates

  • 30% global population suffers from allergic rhinitis (WHO).
  • Pediatric food allergies up 72% since 2000.

2. Regulatory Support

  • FDA’s 2024 Guidance: Expedited Review for Allergy Biologics.
  • EU’s ATMP Classification: Cell-based immunotherapies are gaining R&D funding.

3. Patient Demand for Curative Solutions

  • 70% of patients prefer immunotherapy over antihistamines (AAAI survey).
  • 85% adherence rate for SLIT vs. 45% for injections (SCIT).

Competitive Landscape

Company

Market Share

Flagship Product

Strategic Edge

ALK-Abelló

32%

Palforzia® (Peanut)

FDA-first biologic approval

Stallergenes Greer

24%

Oralair® (Grass Pollen)

SLIT market leader

DBV Technologies

15%

Viaskin™ Patch (Milk)

Non-invasive innovation

Emerging Disruptors:

  • Circassia’s ToleroMune®: T-cell tolerance therapy (Phase II).
  • Anergis’ Ultra-Short Course: 4-injection regimen for pollen allergies.

Market Segmentation

  • By Product:
    • Subcutaneous (SCIT) (55%): Traditional allergy shots.
    • Sublingual (SLIT) (XX%): Tablets/drops (growing at 18% CAGR).
    • Epicutaneous (XX%): Patches (Viaskin™).
  • By Allergy Type:
    • Respiratory (XX%): Pollen, dust mites.
    • Food (XX%): Peanut, milk.
  • By Region:
    • North America (45%): High biologic adoption.
    • Europe (XX%): SLIT dominance.
    • Asia-Pacific (XX%): Untapped potential.

Recent Developments (2024)

  • April 2024: FDA approves Stallergenes’ 5-grass SLIT tablet.
  • July 2024: ALK-Abelló partners with Sanofi on mRNA allergy vaccines.
Unlock the executive summary.
Request the sample to review key questions answered.
See what’s included.
Request sample for scope, definitions and segmentation.

Key Players

  • Allergy Immunotherapy Market – Stallergenes Greer
  • ALK-Abelló A/S
  • Merck KGaA
  • Allergy Therapeutics
  • HAL Allergy Group
  • DBV Technologies
  • Jubilant HollisterStier
  • Anergis SA
  • Biomay AG
  • Circassia Pharmaceuticals.
Competitive Dashboard Preview
Shortlist strategic accounts and benchmark positioning.
Loading…
Request Competitive Cut

Segmentation Explorer

Interactively explore markets by segment and geography.
Refine View
Opportunity Index
Directional signals for prioritization and scenario framing.
Interactive
Need a board-ready slide? .
Modeling inputs: analyst assumptions, secondary sources, triangulated validations.

Table Of Contents

Expandable preview of coverage and chapter structure.

Global Allergy Immunotherapy Market Report

Global Allergy Immunotherapy Market Report


  1. 1. Global Allergy Immunotherapy Market Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global Allergy Immunotherapy Market - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
    2. Global Allergy Immunotherapy Market Research Report - Preface
    1. 2.1 Global Allergy Immunotherapy Market Research Report – Detailed Scope and Definitions
      1. 2.1.1 By Type
      2. 2.1.2 By Allergy Type
      3. 2.1.3 By End-user
      4. 2.1.4 By Region
    3. Global Allergy Immunotherapy Market Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – By Type, By Allergy Type, By End-user, By Country
    3. 3.3. Opportunities – By Type, By Allergy Type, By End-user, By Country
    4. 3.4. Trends – By Type, By Allergy Type, By End-user, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global Allergy Immunotherapy Market Research Report – DROTs Impact Analysis
    4. Global Allergy Immunotherapy Market Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Global Allergy Immunotherapy Market, By Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 5.1 Subcutaneous Immunotherapy (SCIT)
      1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 5.2 Sublingual Immunotherapy (SLIT)
      1. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global Allergy Immunotherapy Market, By Allergy Type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 6.1 Seasonal Allergies
      1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 6.2 Perennial Allergies
      1. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 6.3 Food Allergies
      1. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 6.4 Others
      1. 6.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 6.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 6.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 6.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global Allergy Immunotherapy Market, By End-user, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 7.1 Hospitals
      1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 7.2 Clinics
      1. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 7.3 Homecare.
      1. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Global Allergy Immunotherapy Market Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
    1. 8.1 North America
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    2. 8.2 Europe
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    3. 8.3 Asia-Pacific
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    4. 8.4 Latin America
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 8.5 Middle East & Africa
      1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. 8.6 Global Allergy Immunotherapy Market - Opportunity Analysis Index, By Type, By Allergy Type, By End-user, and Region, 2024 - 2031
    9. North America Allergy Immunotherapy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 9.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 Subcutaneous Immunotherapy (SCIT)
      2. 9.1.2 Sublingual Immunotherapy (SLIT)
      9.2 By Allergy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 Seasonal Allergies
      2. 9.2.2 Perennial Allergies
      3. 9.2.3 Food Allergies
      4. 9.2.4 Others
      9.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 Hospitals
      2. 9.3.2 Clinics
      3. 9.3.3 Homecare.
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 United States
      2. 9.4.2 Canada
      9.5 North America Global Allergy Immunotherapy Market – Opportunity Analysis Index, By Type, By Allergy Type, By End-user, and Country, 2024 - 2031
      9.6 Regional Trends Analysis
      9.7 North America Global Allergy Immunotherapy Market Research Report - Company Profiles
      1. 9.7.1 Company 1 (United States)
      2. 9.7.2 Company 2 (Canada)
      3. 9.7.3 Company 3 (Canada)
    10. Europe Allergy Immunotherapy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 10.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 Subcutaneous Immunotherapy (SCIT)
      2. 10.1.2 Sublingual Immunotherapy (SLIT)
      10.2 By Allergy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 Seasonal Allergies
      2. 10.2.2 Perennial Allergies
      3. 10.2.3 Food Allergies
      4. 10.2.4 Others
      10.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 Hospitals
      2. 10.3.2 Clinics
      3. 10.3.3 Homecare.
      10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Germany
      2. 10.4.2 United Kingdom
      3. 10.4.3 France
      4. 10.4.4 Spain
      5. 10.4.5 Italy
      6. 10.4.6 Russia
      7. 10.4.7 Netherlands
      8. 10.4.8 Poland
      9. 10.4.9 Rest of Europe
      10.5 Europe Global Allergy Immunotherapy Market – Opportunity Analysis Index, By Type, By Allergy Type, By End-user, and Country, 2024 - 2031
      10.6 Regional Trends Analysis
      10.7 Europe Global Allergy Immunotherapy Market Research Report - Company Profiles
      1. 10.7.1 Company 1 (Germany)
      2. 10.7.2 Company 2 (United Kingdom)
      3. 10.7.3 Company 3 (United Kingdom)
    11. Asia-Pacific Allergy Immunotherapy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 11.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 Subcutaneous Immunotherapy (SCIT)
      2. 11.1.2 Sublingual Immunotherapy (SLIT)
      11.2 By Allergy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 Seasonal Allergies
      2. 11.2.2 Perennial Allergies
      3. 11.2.3 Food Allergies
      4. 11.2.4 Others
      11.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 Hospitals
      2. 11.3.2 Clinics
      3. 11.3.3 Homecare.
      11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 China
      2. 11.4.2 Japan
      3. 11.4.3 India
      4. 11.4.4 South Korea
      5. 11.4.5 Australia & NZ
      6. 11.4.6 ASEAN
      7. 11.4.7 Rest of Asia-Pacific
      11.5 Asia-Pacific Global Allergy Immunotherapy Market – Opportunity Analysis Index, By Type, By Allergy Type, By End-user, and Country, 2024 - 2031
      11.6 Regional Trends Analysis
      11.7 Asia-Pacific Global Allergy Immunotherapy Market Research Report - Company Profiles
      1. 11.7.1 Company 1 (China)
      2. 11.7.2 Company 2 (Japan)
      3. 11.7.3 Company 3 (Japan)
    12. Latin America Allergy Immunotherapy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 12.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 Subcutaneous Immunotherapy (SCIT)
      2. 12.1.2 Sublingual Immunotherapy (SLIT)
      12.2 By Allergy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 Seasonal Allergies
      2. 12.2.2 Perennial Allergies
      3. 12.2.3 Food Allergies
      4. 12.2.4 Others
      12.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 Hospitals
      2. 12.3.2 Clinics
      3. 12.3.3 Homecare.
      12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Brazil
      2. 12.4.2 Mexico
      3. 12.4.3 Argentina
      4. 12.4.4 Peru
      5. 12.4.5 Colombia
      6. 12.4.6 Rest of Latin America
      12.5 Latin America Global Allergy Immunotherapy Market – Opportunity Analysis Index, By Type, By Allergy Type, By End-user, and Country, 2024 - 2031
      12.6 Regional Trends Analysis
      12.7 Latin America Global Allergy Immunotherapy Market Research Report - Company Profiles
      1. 12.7.1 Company 1 (Brazil)
      2. 12.7.2 Company 2 (Mexico)
      3. 12.7.3 Company 3 (Mexico)
    13. Middle East & Africa Allergy Immunotherapy Market Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
    1. 13.1 By Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 Subcutaneous Immunotherapy (SCIT)
      2. 13.1.2 Sublingual Immunotherapy (SLIT)
      13.2 By Allergy Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 Seasonal Allergies
      2. 13.2.2 Perennial Allergies
      3. 13.2.3 Food Allergies
      4. 13.2.4 Others
      13.3 By End-user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 Hospitals
      2. 13.3.2 Clinics
      3. 13.3.3 Homecare.
      13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Saudi Arabia
      2. 13.4.2 UAE
      3. 13.4.3 South Africa
      4. 13.4.4 Egypt
      5. 13.4.5 Israel
      6. 13.4.6 Rest of Middle East and Africa
      13.5 Middle East & Africa Global Allergy Immunotherapy Market – Opportunity Analysis Index, By Type, By Allergy Type, By End-user, and Country, 2024 - 2031
      13.6 Regional Trends Analysis
      13.7 Middle East & Africa Global Allergy Immunotherapy Market Research Report - Company Profiles
      1. 13.7.1 Company 1 (Saudi Arabia)
      2. 13.7.2 Company 2 (UAE)
      3. 13.7.3 Company 3 (UAE)
    14. Competition Landscape
    1. 14.1 Strategic Dashboard of Top Market Players
      14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 14.2.1 Allergy Immunotherapy Market – Stallergenes Greer
      2. 14.2.2 ALK-Abelló A/S
      3. 14.2.3 Merck KGaA
      4. 14.2.4 Allergy Therapeutics
      5. 14.2.5 HAL Allergy Group
      6. 14.2.6 DBV Technologies
      7. 14.2.7 Jubilant HollisterStier
      8. 14.2.8 Anergis SA
      9. 14.2.9 Biomay AG
      10. 14.2.10 Circassia Pharmaceuticals.
    15. Data Collection Method and Research Approach
    16. Principal Presumptions and Acronyms

Methodology & Credibility

Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.
Book A Consultation
Preferred by strategy, marketing, and corporate development teams.

Related Reports

More coverage in adjacent themes and segments.
Ready to move from data to decision?
Get the report, request a sample, or book a consultative briefing.
New chat message received
×

Need help?

Chat with our team in a minute.